15 July 2020 - The pharmaceutical business is perhaps the only industry on the planet, where to get the product from idea to market the company needs to spend about a decade, several billion dollars, and there is about 90% chance of failure. 

It is very different from the IT business, where only the paranoid survive but a business where executives need to plan decades ahead and execute. So when the revolution in artificial intelligence fuelled by credible advances in deep learning hit in 2013-2014, the pharmaceutical industry executives got interested but did not immediately jump on the bandwagon. 

Many pharmaceutical companies started investing heavily in internal data science R&D but without a coordinated strategy it looked more like re-branding exercise with the many heads of data science, digital, and AI in one organisation and often in one department.

Read Forbes article